SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
O
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
1.132 |
Evidence |
|
MMP13 |
MMP13: Collagenase 3 precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.132 |
Evidence |
|
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
1.132 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINA3 |
IPI00550991 |
1.132 |
Evidence |
|
NOG |
NOG: Noggin precursor |
BMP7 |
BMP7, OP1: Bone morphogenetic protein 7 precursor |
1.132 |
Evidence |
O
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
1.132 |
Evidence |
|
APOA1 |
APOA1: Apolipoprotein A-I precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
1.132 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
IL4 |
IL4: Interleukin-4 precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
GTF2F2 |
IPI00329767 |
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
1.13 |
Evidence |
O
|
NRAS |
HRAS, HRAS1: GTPase HRas precursor |
RASSF1 |
RASSF1, RDA32: Ras association domain-containing protein 1 |
1.122 |
Evidence |
|
SLIT3 |
SLIT3, KIAA0814, UNQ691/PRO1336, MEGF5, SLIL2: Slit homolog 3 protein precursor |
ROBO2 |
IPI00385980 |
1.122 |
Evidence |
|
RAB5B |
RAB5B: Ras-related protein Rab-5B |
RIN2 |
RIN2, RASSF4: Ras and Rab interactor 2 |
1.122 |
Evidence |
|
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
1.122 |
Evidence |
|
CCDC53 |
CCDC53, AD-016, CGI-116, x0009: Coiled-coil domain-containing protein 53 |
HSBP1 |
HSBP1, HSF1BP: Heat shock factor-binding protein 1 |
1.117 |
Evidence |
O
|
BID |
BID: BH3-interacting domain death agonist |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
1.112 |
Evidence |
|
GRAP |
GRAP: GRB2-related adapter protein |
RICS |
RICS: Rac GTPase activating protein |
1.11 |
Evidence |
|
CSPG6 |
SMC3, BAM, BMH, CSPG6, SMC3L1: Structural maintenance of chromosomes protein 3 |
SMC1L2 |
SMC1B, SMC1L2: Structural maintenance of chromosomes protein 1B |
1.102 |
Evidence |
|
PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
PPP2R5E |
PPP2R5E: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsil |
1.095 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
WIRE |
WIPF2, WICH, PP10631, WIRE: WAS/WASL-interacting protein family member 2 |
1.095 |
Evidence |
|
PPP4C |
PPP4C, PPP4, PPX: Serine/threonine-protein phosphatase 4 catalytic subunit |
IGBP1 |
IGBP1, IBP1: Immunoglobulin-binding protein 1 |
1.087 |
Evidence |
O
|
RGS12 |
RGS12: Regulator of G-protein signaling 12 |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
1.08 |
Evidence |
|